Abstract 7050: A novel 149-amino acid protein encoded by circSOD2 inhibits ferroptosis and promotes cisplatin resistance in bladder cancer.
Abstract Circular RNAs (circRNAs) play pivotal roles in bladder cancer (BCa) tumorigenesis, metastasis, and chemoresistance, but their functional involvement in cisplatin-induced ferroptosis remains poorly defined. Herein, we identified circSOD2 as a significantly upregulated circRNA in cisplatin-resistant BCa cell lines and clinical specimens via RNA sequencing. Functional assays demonstrated that circSOD2 overexpression enhanced BCa cell proliferation and cisplatin resistance in vitro (CCK-8, colony formation, and ferroptosis detection assays) and in vivo (xenograft mouse models). Mechanistically, ribosome profiling and Western blot analyses confirmed the protein-coding potential of circSOD2, which translates into a novel 149-amino acid peptide (SOD2-149aa). Co-immunoprecipitation (Co-IP) and glutathione S-transferase (GST) pull-down assays verified that SOD2-149aa directly binds to the RING domain of tripartite motif 26 (TRIM26), a ubiquitin E3 ligase. This interaction activates TRIM26-mediated K63-linked polyubiquitination of glutathione peroxidase 4 (GPX4) — a key anti-ferroptotic enzyme — at lysine residue 148, thereby preventing GPX4 proteasomal degradation and enhancing its protein stability. Stabilized GPX4 efficiently scavenges lipid reactive oxygen species (ROS) and reduces iron-dependent lipid peroxidation, ultimately mitigating cisplatin-induced ferroptosis and conferring cisplatin resistance in BCa. Conversely, circSOD2 silencing or SOD2-149aa knockout abrogated TRIM26-GPX4 interaction, diminished GPX4 stability, and restored BCa cell sensitivity to cisplatin. Collectively, our findings uncover a novel circRNA-encoded peptide that regulates ferroptosis and chemoresistance via the TRIM26-GPX4 axis, highlighting circSOD2/SOD2-149aa as a promising prognostic biomarker and therapeutic target for overcoming cisplatin resistance in BCa. Citation Format: Shanqi Guo, Zhihong Lv, Nan Wang, Xingkang Jiang. A novel 149-amino acid protein encoded by circSOD2 inhibits ferroptosis and promotes cisplatin resistance in bladder cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 7050.
Authors
- Xingkang Jiang (ORCID: https://orcid.org/0000-0003-3084-1655)
- Zhihong Lv (ORCID: https://orcid.org/0000-0002-9992-6895)
- S Guo
- Nan Wang
Institutions
- Tianjin University of Traditional Chinese Medicine (CN)
- Atrium Health Wake Forest Baptist (US)
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (CN)
- Second Hospital of Tianjin Medical University (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Cancer Research
- Published
- 2026-04-03
- DOI
- https://doi.org/10.1158/1538-7445.am2026-7050
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00